Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation.

Hernandez W, Danahey K, Pei X, Yeo KJ, Leung E, Volchenboum SL, Ratain MJ, Meltzer DO, Stranger BE, Perera MA, O'Donnell PH.

Pharmacogenomics J. 2019 Sep 11. doi: 10.1038/s41397-019-0095-z. [Epub ahead of print]

PMID:
31506565
2.

Obtaining Knowledge in Pathology Reports Through a Natural Language Processing Approach With Classification, Named-Entity Recognition, and Relation-Extraction Heuristics.

Oliwa T, Maron SB, Chase LM, Lomnicki S, Catenacci DVT, Furner B, Volchenboum SL.

JCO Clin Cancer Inform. 2019 Aug;3:1-8. doi: 10.1200/CCI.19.00008.

3.

Using photoplethysmography data to estimate heart rate variability and its association with organ dysfunction in pediatric oncology patients.

Mayampurath A, Volchenboum SL, Sanchez-Pinto LN.

NPJ Digit Med. 2018 Jul 25;1:29. doi: 10.1038/s41746-018-0038-0. eCollection 2018.

4.

The Global academic research organization network: Data sharing to cure diseases and enable learning health systems.

Fukushima M, Austin C, Sato N, Maruyama T, Navarro E, Rocca M, Demotes J, Haendel M, Volchenboum SL, Cowperthwaite M, Silverstein JC, Webb C, Sim I, Chase M, Speakman J, Augustine E, Ford DE, Kush R.

Learn Health Syst. 2018 Dec 3;3(1):e10073. doi: 10.1002/lrh2.10073. eCollection 2019 Jan.

5.

Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials.

Cox SM, Lane A, Volchenboum SL.

JCO Clin Cancer Inform. 2018 Dec;2:1-11. doi: 10.1200/CCI.17.00147. Review.

6.

Scalable and accurate deep learning with electronic health records.

Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, Liu PJ, Liu X, Marcus J, Sun M, Sundberg P, Yee H, Zhang K, Zhang Y, Flores G, Duggan GE, Irvine J, Le Q, Litsch K, Mossin A, Tansuwan J, Wang, Wexler J, Wilson J, Ludwig D, Volchenboum SL, Chou K, Pearson M, Madabushi S, Shah NH, Butte AJ, Howell MD, Cui C, Corrado GS, Dean J.

NPJ Digit Med. 2018 May 8;1:18. doi: 10.1038/s41746-018-0029-1. eCollection 2018.

7.

System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.

Kang W, Kadri S, Puranik R, Wurst MN, Patil SA, Mujacic I, Benhamed S, Niu N, Zhen CJ, Ameti B, Long BC, Galbo F, Montes D, Iracheta C, Gamboa VL, Lopez D, Yourshaw M, Lawrence CA, Aisner DL, Fitzpatrick C, McNerney ME, Wang YL, Andrade J, Volchenboum SL, Furtado LV, Ritterhouse LL, Segal JP.

J Mol Diagn. 2018 Jul;20(4):522-532. doi: 10.1016/j.jmoldx.2018.03.008. Epub 2018 Apr 24.

8.

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.

Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Maris JM, Diskin SJ, Onel K, Cohn SL.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx093.

9.

Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.

Danahey K, Borden BA, Furner B, Yukman P, Hussain S, Saner D, Volchenboum SL, Ratain MJ, O'Donnell PH.

J Biomed Inform. 2017 Nov;75:110-121. doi: 10.1016/j.jbi.2017.09.012. Epub 2017 Sep 28.

10.

Data Commons to Support Pediatric Cancer Research.

Volchenboum SL, Cox SM, Heath A, Resnick A, Cohn SL, Grossman R.

Am Soc Clin Oncol Educ Book. 2017;37:746-752. doi: 10.14694/EDBK_175029. Review.

PMID:
28561664
11.

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ.

Clin Pharmacol Ther. 2017 Nov;102(5):859-869. doi: 10.1002/cpt.709. Epub 2017 Jun 15.

12.

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Applebaum MA, Vaksman Z, Lee SM, Hungate EA, Henderson TO, London WB, Pinto N, Volchenboum SL, Park JR, Naranjo A, Hero B, Pearson AD, Stranger BE, Cohn SL, Diskin SJ.

Eur J Cancer. 2017 Feb;72:177-185. doi: 10.1016/j.ejca.2016.11.022. Epub 2016 Dec 26.

13.

Association Between In-Hospital Critical Illness Events and Outcomes in Patients on the Same Ward.

Volchenboum SL, Mayampurath A, Göksu-Gürsoy G, Edelson DP, Howell MD, Churpek MM.

JAMA. 2016 Dec 27;316(24):2674-2675. doi: 10.1001/jama.2016.15505. No abstract available.

14.

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.

Eckert MA, Pan S, Hernandez KM, Loth RM, Andrade J, Volchenboum SL, Faber P, Montag A, Lastra R, Peter ME, Yamada SD, Lengyel E.

Cancer Discov. 2016 Dec;6(12):1342-1351. Epub 2016 Oct 7.

15.

A method for whole protein isolation from human cranial bone.

Lyon SM, Mayampurath A, Rogers MR, Wolfgeher DJ, Fisher SM, Volchenboum SL, He TC, Reid RR.

Anal Biochem. 2016 Dec 15;515:33-39. doi: 10.1016/j.ab.2016.09.021. Epub 2016 Sep 25.

16.

Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.

Morgenstern DA, London WB, Stephens D, Volchenboum SL, Simon T, Nakagawara A, Shimada H, Schleiermacher G, Matthay KK, Cohn SL, Pearson AD, Irwin MS.

Eur J Cancer. 2016 Sep;65:1-10. doi: 10.1016/j.ejca.2016.06.005. Epub 2016 Jul 17.

PMID:
27434878
17.

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CP.

Pediatr Blood Cancer. 2016 Aug;63(8):1349-56. doi: 10.1002/pbc.25994. Epub 2016 Apr 19.

PMID:
27092812
18.

Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.

Bagatell R, McHugh K, Naranjo A, Van Ryn C, Kirby C, Brock P, Lyons KA, States LJ, Rojas Y, Miller A, Volchenboum SL, Simon T, Krug B, Sarnacki S, Valteau-Couanet D, von Schweinitz D, Kammer B, Granata C, Pio L, Park JR, Nuchtern J.

J Clin Oncol. 2016 Mar 1;34(7):740-6. doi: 10.1200/JCO.2015.63.2042. Epub 2016 Jan 11.

19.

An Approach to Acquiring, Normalizing, and Managing EHR Data From a Clinical Data Repository for Studying Pressure Ulcer Outcomes.

Padula WV, Blackshaw L, Brindle CT, Volchenboum SL.

J Wound Ostomy Continence Nurs. 2016 Jan-Feb;43(1):39-45. doi: 10.1097/WON.0000000000000185.

PMID:
26727681
20.

Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor.

Rosebeck S, Alonge MM, Kandarpa M, Mayampurath A, Volchenboum SL, Jasielec J, Dytfeld D, Maxwell SP, Kraftson SJ, McCauley D, Shacham S, Kauffman M, Jakubowiak AJ.

Mol Cancer Ther. 2016 Jan;15(1):60-71. doi: 10.1158/1535-7163.MCT-15-0488. Epub 2015 Dec 4.

21.

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL.

J Clin Oncol. 2015 Sep 20;33(27):3008-17. doi: 10.1200/JCO.2014.59.4648. Epub 2015 Aug 24. Review.

22.

The quantitative changes in the yeast Hsp70 and Hsp90 interactomes upon DNA damage.

Truman AW, Kristjansdottir K, Wolfgeher D, Ricco N, Mayampurath A, Volchenboum SL, Clotet J, Kron SJ.

Data Brief. 2014 Nov 7;2:12-5. doi: 10.1016/j.dib.2014.10.006. eCollection 2015 Mar.

23.

Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group.

Volchenboum SL, Andrade J, Huang L, Barkauskas DA, Krailo M, Womer RB, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor ER.

J Pathol Clin Res. 2015 Apr;1(2):83-94.

24.

Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience.

Pinto N, Volchenboum SL, Skol AD, Rhodes L, Doan A, Fein-Levy C, Lipton JM, Cunningham JM, Onel K.

Per Med. 2015 Jun;12(3):221-229. doi: 10.2217/pme.14.90.

PMID:
29771652
25.

N-linked glycan profiling in neuroblastoma cell lines.

Hu Y, Mayampurath A, Khan S, Cohen JK, Mechref Y, Volchenboum SL.

J Proteome Res. 2015 May 1;14(5):2074-81. doi: 10.1021/pr5011718. Epub 2015 Mar 16.

26.

Quantitative proteomics of the yeast Hsp70/Hsp90 interactomes during DNA damage reveal chaperone-dependent regulation of ribonucleotide reductase.

Truman AW, Kristjansdottir K, Wolfgeher D, Ricco N, Mayampurath A, Volchenboum SL, Clotet J, Kron SJ.

J Proteomics. 2015 Jan 1;112:285-300. doi: 10.1016/j.jprot.2014.09.028. Epub 2014 Oct 18.

27.

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Applebaum MA, Henderson TO, Lee SM, Pinto N, Volchenboum SL, Cohn SL.

Pediatr Blood Cancer. 2015 Jan;62(1):128-33. doi: 10.1002/pbc.25249. Epub 2014 Sep 23.

28.

CAPriCORN: Chicago Area Patient-Centered Outcomes Research Network.

Kho AN, Hynes DM, Goel S, Solomonides AE, Price R, Hota B, Sims SA, Bahroos N, Angulo F, Trick WE, Tarlov E, Rachman FD, Hamilton A, Kaleba EO, Badlani S, Volchenboum SL, Silverstein JC, Tobin JN, Schwartz MA, Levine D, Wong JB, Kennedy RH, Krishnan JA, Meltzer DO, Collins JM, Mazany T; CAPriCORN Team.

J Am Med Inform Assoc. 2014 Jul-Aug;21(4):607-11. doi: 10.1136/amiajnl-2014-002827. Epub 2014 May 12.

29.

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

Morgenstern DA, London WB, Stephens D, Volchenboum SL, Hero B, Di Cataldo A, Nakagawara A, Shimada H, Ambros PF, Matthay KK, Cohn SL, Pearson AD, Irwin MS.

J Clin Oncol. 2014 Apr 20;32(12):1228-35. doi: 10.1200/JCO.2013.53.6342. Epub 2014 Mar 24.

30.

Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaboration.

Kirby C, Ambros PF, Billiter D, London WB, Mendonca E, Monclair T, Pearson AD, Cohn SL, Volchenboum SL.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:103. eCollection 2013.

PMID:
24303312
31.

A novel algorithm for simplification of complex gene classifiers in cancer.

Wilson RA, Teng L, Bachmeyer KM, Bissonnette ML, Husain AN, Parham DM, Triche TJ, Wing MR, Gastier-Foster JM, Barr FG, Hawkins DS, Anderson JR, Skapek SX, Volchenboum SL.

Cancer Res. 2013 Sep 15;73(18):5625-32. doi: 10.1158/0008-5472.CAN-13-0324. Epub 2013 Aug 2.

32.

Collection of peripheral blood stem cells from a 7 month-old girl weighing 7 kg with the use of combined heparin and citrate anticoagulation.

Mandal S, Baron BW, Mischeaux M, James K, Roig J, Landers J, Volchenboum SL, Cunningham JM, Reardon B, Musa G, Richa EM.

J Clin Apher. 2013 Aug;28(4):309-10. doi: 10.1002/jca.21271. Epub 2013 Jul 24. No abstract available.

PMID:
23881772
33.

Bioinformatic analysis and post-translational modification crosstalk prediction of lysine acetylation.

Lu Z, Cheng Z, Zhao Y, Volchenboum SL.

PLoS One. 2011;6(12):e28228. doi: 10.1371/journal.pone.0028228. Epub 2011 Dec 2.

34.

Development of warm auto- and allo-antibodies in a 3-year old boy with sickle cell haemoglobinopathy following his first transfusion of a single unit of red blood cells.

McNerney ME, Baron BW, Volchenboum SL, Papari M, Keith M, Williams K, Richa E.

Blood Transfus. 2010 Apr;8(2):126-8. doi: 10.2450/2009.0105-09. No abstract available.

35.

Are molecular neuroblastoma classifiers ready for prime time?

Volchenboum SL, Cohn SL.

Lancet Oncol. 2009 Jul;10(7):641-2. doi: 10.1016/S1470-2045(09)70176-7. No abstract available.

PMID:
19573794
36.

Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.

Volchenboum SL, Li C, Li S, Attiyeh EF, Reynolds CP, Maris JM, Look AT, George RE.

Cancer Res. 2009 May 15;69(10):4143-9. doi: 10.1158/0008-5472.CAN-08-3112. Epub 2009 May 12.

37.

Rapid validation of Mascot search results via stable isotope labeling, pair picking, and deconvolution of fragmentation patterns.

Volchenboum SL, Kristjansdottir K, Wolfgeher D, Kron SJ.

Mol Cell Proteomics. 2009 Aug;8(8):2011-22. doi: 10.1074/mcp.M800472-MCP200. Epub 2009 May 11.

38.

Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside.

Volchenboum SL, Cohn SL.

J Clin Oncol. 2009 Mar 1;27(7):1003-4. doi: 10.1200/JCO.2008.20.2739. Epub 2009 Jan 26. No abstract available.

PMID:
19171702
39.

3 + 3 not equal to (Rolling) 6.

Hartford C, Volchenboum SL, Cohn SL.

J Clin Oncol. 2008 Jan 10;26(2):170-1. doi: 10.1200/JCO.2007.14.5052. No abstract available.

PMID:
18182656
40.

Arginine 387 of human isovaleryl-CoA dehydrogenase plays a crucial role in substrate/product binding.

Volchenboum SL, Mohsen AW, Kim JJ, Vockley J.

Mol Genet Metab. 2001 Sep-Oct;74(1-2):226-37.

PMID:
11592819
41.
42.

Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia.

Mohsen AW, Anderson BD, Volchenboum SL, Battaile KP, Tiffany K, Roberts D, Kim JJ, Vockley J.

Biochemistry. 1998 Jul 14;37(28):10325-35.

PMID:
9665741

Supplemental Content

Loading ...
Support Center